Kalubi Kalenga
Biographic Data
| ID | 7789840 |
|---|---|
| NAME | Kalubi Kalenga |
| GIVEN NAMES | Kalubi |
| FAMILY NAME | Kalenga |
| SIGNATURE | KALENGA K |
| AFFILIATIONS | Centre for Infectious Disease Research in Zambia |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Implementing Sars-CoV-2 routine surveillance in antenatal care in Zambia, 2021–2022
Incorporating SARS-CoV-2 surveillance into routine antenatal care is feasible and potentially sustainable when existing health system infrastructure, human resources, and surveillance systems are leveraged. Yet, careful planning is needed to anticipate implementation challenges and ensure high-quality data collection
Covid-19 vaccine uptake and associated risk factors among first antenatal care attendees in Zambia, 2021–2022
Pregnant women are considered a high-risk group for COVID-19, and a priority for vaccination. Routine antenatal care (ANC) provides an opportunity to track trends and factors associated with vaccine uptake. We sought to evaluate COVID-19 vaccine uptake among pregnant women attending ANC and assess the factors associated with vaccine in Zambia. We conducted a repeated cross-sectional study in 39 public health facilities in four districts in Zambia…
Trends in Sars-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia
SARS-CoV-2 serosurveys help estimate the extent of transmission and guide the allocation of COVID-19 vaccines. We measured SARS-CoV-2 seroprevalence among women attending ANC clinics to assess exposure trends over time in Zambia. We conducted repeated cross-sectional SARS-CoV-2 seroprevalence surveys among pregnant women aged 15–49 years attending their first ANC visits in four districts of Zambia (two urban and two rural) during September 2021-S…
No prominent works on this page.
Covid-19 vaccine uptake and associated risk factors among first antenatal care attendees in Zambia, 2021–2022
Pregnant women are considered a high-risk group for COVID-19, and a priority for vaccination. Routine antenatal care (ANC) provides an opportunity to track trends and factors associated with vaccine uptake. We sought to evaluate COVID-19 vaccine uptake among pregnant women attending ANC and assess the factors associated with vaccine in Zambia. We conducted a repeated cross-sectional study in 39 public health facilities in four districts in Zambia…
Trends in Sars-CoV-2 seroprevalence among pregnant women attending first antenatal care visits in Zambia
SARS-CoV-2 serosurveys help estimate the extent of transmission and guide the allocation of COVID-19 vaccines. We measured SARS-CoV-2 seroprevalence among women attending ANC clinics to assess exposure trends over time in Zambia. We conducted repeated cross-sectional SARS-CoV-2 seroprevalence surveys among pregnant women aged 15–49 years attending their first ANC visits in four districts of Zambia (two urban and two rural) during September 2021-S…
Implementing Sars-CoV-2 routine surveillance in antenatal care in Zambia, 2021–2022
Incorporating SARS-CoV-2 surveillance into routine antenatal care is feasible and potentially sustainable when existing health system infrastructure, human resources, and surveillance systems are leveraged. Yet, careful planning is needed to anticipate implementation challenges and ensure high-quality data collection
Medicine (3 works) · Pediatrics (3 works) · COVID-19 Impact on Reproduction (2 works) · Cross-sectional study (2 works) · Disease (2 works) · Environmental health (2 works) · Immunology (2 works) · Internal Medicine (2 works) · Vaccination (2 works) · Vaccine Coverage and Hesitancy (2 works)